Janus Henderson Group’s Meridian Bioscience Inc VIVO Stock Holding History

Janus Henderson Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-418,615	Closed	-$13.9M	–	2827
2022 Q4	$13.9M	Buy	418,615 +99,714	+31%	+$3.21M	0.01%	644
2022 Q3	$10.1M	Buy	318,901 +274,012	+610%	+$8.87M	0.01%	675
2022 Q2	$1.36M	Sell	44,889 -7,279	-14%	-$197K	﹤0.01%	1189
2022 Q1	$1.35M	Buy	52,168 +13,806	+36%	+$328K	﹤0.01%	1384
2021 Q4	$782K	Buy	+38,362	New	+$736K	﹤0.01%	1621

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Janus Henderson Group's VIVO Position: Q1 2023 in Review

Janus Henderson Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 418,615 shares — an estimated $13.9M sold.

Janus Henderson Group first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $13.9M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Janus Henderson Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Janus Henderson Group sold 418,615 Meridian Bioscience Inc shares in Q1 2023, an estimated $13.9M.
Janus Henderson Group first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Janus Henderson Group's Meridian Bioscience Inc position peaked at $13.9M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.